Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Yukari Yamanaka

Biographic Data

ID9008200
NAMEYukari Yamanaka
GIVEN NAMESYukari
FAMILY NAMEYamanaka
SIGNATUREYAMANAKA Y
AFFILIATIONSThe University of Tokyo
VERIFIEDNo
TOTAL WORKS3
TOTAL CITATIONS0
WORKS AS AUTHOR3
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2023
LATEST PUBLICATION YEAR2025
H-INDEX0
  • The impact of the prolonged Covid-19 pandemic on the practice of psychosomatic medicine in Japan

    Open Access•Yukari Yamanaka, Kazuhiro Yoshiuchi et al.•ARTICLE•BioPsychoSocial Medicine•2025

    BACKGROUND: The prolonged COVID-19 pandemic has significantly affected the clinical care and the mental health of patients in psychosomatic medicine. Between late 2021 and early 2022, the Japanese Society of Psychosomatic Medicine (JSPM) and the Japanese Society of Psychosomatic Internal Medicine (JSPIM) conducted a nationwide physician survey to assess these effects. The survey identified difficulties in outpatient and inpatient care, increased …

  • A multi-center, randomized, parallel-group study to compare the efficacy of enhanced cognitive behavior therapy (CBT-E) with treatment as usual (TAU) for anorexia nervosa

    Open Access•Nobuhiro Nohara, Yukari Yamanaka et al.•ARTICLE•BioPsychoSocial Medicine•2023

    Background The superiority of Enhanced Cognitive Behavior Therapy (CBT-E) with regard to weight gain and improvement of psychopathology of eating disorders for patients with anorexia nervosa (AN) over other psychotherapies and treatment as usual (TAU) has not been demonstrated in randomized controlled trials (RCTs). However, a previous RCT showed that patients with AN whose baseline body mass index (BMI) was less than 17.5 kg/m 2 gained more weig…

  • A nationwide questionnaire survey of physicians regarding the impact of the Covid-19 pandemic on patients and treatment system of psychosomatic medicine

    Open Access•Yukari Yamanaka, Kazuhiro Yoshiuchi et al.•ARTICLE•BioPsychoSocial Medicine•2023

    BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has affected the treatment system of medical institutions across the world. Studies of the populations and patients have reported mental health problems caused by the pandemic. However, there are few large-scale studies that have examined the effects of the COVID-19 on diseases from the perspective of psychosomatic medicine. The purpose of this study was to examine changes made to the p…

No prominent works on this page.

  • A multi-center, randomized, parallel-group study to compare the efficacy of enhanced cognitive behavior therapy (CBT-E) with treatment as usual (TAU) for anorexia nervosa

    Open Access•Nobuhiro Nohara, Yukari Yamanaka et al.•ARTICLE•BioPsychoSocial Medicine•2023

    Background The superiority of Enhanced Cognitive Behavior Therapy (CBT-E) with regard to weight gain and improvement of psychopathology of eating disorders for patients with anorexia nervosa (AN) over other psychotherapies and treatment as usual (TAU) has not been demonstrated in randomized controlled trials (RCTs). However, a previous RCT showed that patients with AN whose baseline body mass index (BMI) was less than 17.5 kg/m 2 gained more weig…

  • A nationwide questionnaire survey of physicians regarding the impact of the Covid-19 pandemic on patients and treatment system of psychosomatic medicine

    Open Access•Yukari Yamanaka, Kazuhiro Yoshiuchi et al.•ARTICLE•BioPsychoSocial Medicine•2023

    BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has affected the treatment system of medical institutions across the world. Studies of the populations and patients have reported mental health problems caused by the pandemic. However, there are few large-scale studies that have examined the effects of the COVID-19 on diseases from the perspective of psychosomatic medicine. The purpose of this study was to examine changes made to the p…

  • The impact of the prolonged Covid-19 pandemic on the practice of psychosomatic medicine in Japan

    Open Access•Yukari Yamanaka, Kazuhiro Yoshiuchi et al.•ARTICLE•BioPsychoSocial Medicine•2025

    BACKGROUND: The prolonged COVID-19 pandemic has significantly affected the clinical care and the mental health of patients in psychosomatic medicine. Between late 2021 and early 2022, the Japanese Society of Psychosomatic Medicine (JSPM) and the Japanese Society of Psychosomatic Internal Medicine (JSPIM) conducted a nationwide physician survey to assess these effects. The survey identified difficulties in outpatient and inpatient care, increased …

Internal Medicine (3 works) · Medicine (3 works) · Psychiatry (3 works) · COVID-19 and Mental Health (2 works) · Disease (2 works) · Family medicine (2 works) · Long-Term Effects of COVID-19 (2 works) · Pandemic (2 works) · Psychosomatic medicine (2 works) · Telemedicine and Telehealth Implementation (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae